
51 - 200 funcionários
Fundada em 2019
🧬 Biotecnologia
💊 Farmacêutico
🔬 Ciência
💰 $85.000.000 Series B em 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics é uma empresa biofarmacêutica centrada no paciente e em estágio clínico, focada no desenvolvimento de terapias celulares para pacientes que sofrem de doenças autoimunes. A empresa está na vanguarda das terapias com células CAR T, aproveitando o poder transformador das células T para potencialmente proporcionar remissão sustentada e sem tratamento para condições autoimunes. O principal candidato a terapia com células CAR T da Kyverna, o KYV-101, está avançando em ensaios clínicos visando várias doenças autoimunes, incluindo esclerose múltipla, miastenia grave, esclerose sistêmica e nefrite lúpica. Seu pipeline apresenta terapias inovadoras com receptores de antígenos quiméricos (CAR) T-cells em formatos autólogos e alogênicos voltados para doenças autoimunes mediadas por células B.
🕒 Julho 2
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $300.000 - $340.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2019
🧬 Biotecnologia
💊 Farmacêutico
🔬 Ciência
💰 $85.000.000 Series B em 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics é uma empresa biofarmacêutica centrada no paciente e em estágio clínico, focada no desenvolvimento de terapias celulares para pacientes que sofrem de doenças autoimunes. A empresa está na vanguarda das terapias com células CAR T, aproveitando o poder transformador das células T para potencialmente proporcionar remissão sustentada e sem tratamento para condições autoimunes. O principal candidato a terapia com células CAR T da Kyverna, o KYV-101, está avançando em ensaios clínicos visando várias doenças autoimunes, incluindo esclerose múltipla, miastenia grave, esclerose sistêmica e nefrite lúpica. Seu pipeline apresenta terapias inovadoras com receptores de antígenos quiméricos (CAR) T-cells em formatos autólogos e alogênicos voltados para doenças autoimunes mediadas por células B.
• Develop and execute the U.S. sales strategy supporting the commercialization of CAR-T for autoimmune diseases. • Build and lead a best-in-class specialty sales organization capable of supporting current and future product launches. • Establish commercial objectives, territory design, targeting strategies, and deployment models aligned with corporate goals. • Drive revenue growth while ensuring compliance with all regulatory, legal, and company requirements. • Partner with executive leadership to shape long-term commercial strategy and portfolio planning. • Lead commercialization efforts across the CAR-T ecosystem, including treatment centers, referring physicians, infusion centers, and hospital systems. • Develop strategies to optimize treatment center activation, patient identification, referral pathways, and patient access. • Collaborate closely with Market Access, Cell Therapy Operations, Patient Services, and Medical Affairs to ensure seamless therapy adoption. • Understand and address the complexities associated with cell collection, manufacturing, logistics, reimbursement, and site readiness. • Monitor evolving CAR-T market dynamics, competitive intelligence, and emerging treatment paradigms. • Establish and expand relationships with key neurology stakeholders, including academic centers, comprehensive neuroscience programs, and community neurologists. • Drive customer engagement strategies supporting therapies for autoimmune neurological disorders, neurodegenerative diseases, and other complex neurological conditions. • Develop disease-state education and value-based customer engagement approaches. • Partner with Medical Affairs to ensure effective scientific exchange and customer education initiatives. • Recruit, develop, and retain top-performing regional sales leaders and field sales professionals. • Foster a high-performance culture focused on accountability, collaboration, innovation, and patient impact. • Establish performance expectations, coaching programs, succession planning, and talent development initiatives. • Lead ongoing training efforts focused on disease state expertise, clinical data, reimbursement, and customer engagement excellence. • Partner closely with Market Access, Medical Affairs, Marketing, Commercial Operations, Patient Services, Legal, Compliance, and Finance. • Ensure alignment between field execution and broader commercial strategies. • Support forecasting, business planning, resource allocation, and launch readiness activities. • Provide field insights to inform brand strategy, lifecycle planning, and evidence generation priorities. • Establish and monitor KPIs related to sales performance, account engagement, treatment center activation, patient referrals, and market penetration. • Utilize data analytics to optimize territory performance and resource deployment. • Deliver regular business reviews and strategic recommendations to executive leadership. • Identify opportunities to improve commercial effectiveness and customer experience.
• Bachelor's degree required; advanced degree (MBA, PharmD, PhD, or other relevant graduate degree) preferred. • Minimum 15 years of biopharmaceutical commercial experience. • Minimum 8 years of progressive sales leadership experience, including leading national specialty sales teams. • Demonstrated success launching and commercializing specialty, rare disease, neurology, oncology, immunology, or cell and gene therapies. • Deep understanding of specialty reimbursement, payer dynamics, treatment center engagement, and patient access. • Experience managing field teams supporting highly complex therapies and specialized provider networks. • Proven ability to build, lead, and scale high-performing commercial organizations. • Direct CAR-T, cell therapy, gene therapy, or oncology commercialization experience preferred. • Neurology commercialization experience, particularly within autoimmune or rare neurological disorders preferred. • Experience launching products through limited distribution networks and specialized treatment centers preferred. • Strong understanding of buy-and-bill reimbursement models, specialty pharmacy, specialty distribution, and site-of-care considerations preferred.
• This position is also eligible for bonus • benefits • participation in Company’s stock plan
Candidatar-se🕒 Julho 2
Experienced VP/SVP managing insurance regulatory compliance for Lightstone's multi-entity insurance group. Leading compliance oversight across domestic and international insurance companies.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $175.000 - $200.000 / ano
💰 $175.000.000 Debt Financing - The Lightstone Group em 2019-12
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 2
VP Affiliate Growth overseeing franchise renewals and driving market expansion for Century 21. Leading strategic growth initiatives with a focus on network performance in the Eastern Region.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $150.000 - $175.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 2
Senior Consulting Actuary leading client relationships with comprehensive H&W support and innovative solutions at Fidelity. Mentoring associates and collaborating on strategic consulting projects.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $130.000 - $264.000 / ano
💰 $2.000.000 Series unknown em 2024-03
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 2
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $290.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 2
SVP of Product leading the product vision across data, media, and activation for a data and media company. Overseeing product strategy and building a high-performing product team.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $200.000 - $290.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório